Name: Estrella Immunopharma, Inc. (ESLA) Balance Sheet
Creator: FinSpry

Estrella Immunopharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Estrella Immunopharma, Inc. (ESLA) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Jun 2023	Jun 2022	Jun 2021
Current Assets
Cash and Cash Equivalents	0.92	2.48	4.09	0.00
Cash & Short-Term Investments	0.92	2.48	4.09	0.00
Accounts Receivable	0.00	0.27	0.00	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	0.72	0.00	0.83	0.00
Total Current Assets	1.64	2.75	4.92	0.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00
Other Non-Current Assets	1.50	0.00	0.00	0.00
Total Non-Current Assets	1.50	0.28	0.00	0.00
Total Assets	3.14	3.03	4.92	0.00
Current Liabilities
Accounts Payable	0.00	9.33	0.95	0.00
Accrued Liabilities	0.13	0.42	0.03	0.00
Other Current Liabilities	3.00	0.88	0.92	0.00
Total Current Liabilities	3.00	9.76	0.95	0.00
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.01	0.01	0.00
Total Non-Current Liabilities	0.00	5.01	5.01	0.00
Total Liabilities	3.00	14.77	5.96	0.00
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00
Retained Earnings	-23.93	-12.19	-1.07	0.00
Treasury Stock	0.35	0.00	0.00	0.00
Additional Paid-in Capital	24.12	0.45	0.03	0.00
Shares Outstanding	36.29	35.20	35.20	0.00
Total Stockholders' Equity	0.14	-11.74	-1.04	0.00
Total Liabilities & Equity	3.14	3.03	4.92	0.00